These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 30381055)

  • 1. Peptidomimetics Targeting Protein-Protein Interactions for Therapeutic Development.
    Zhang G; Andersen J; Gerona-Navarro G
    Protein Pept Lett; 2018; 25(12):1076-1089. PubMed ID: 30381055
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rational modulator design by exploitation of protein-protein complex structures.
    Wichapong K; Poelman H; Ercig B; Hrdinova J; Liu X; Lutgens E; Nicolaes GA
    Future Med Chem; 2019 May; 11(9):1015-1033. PubMed ID: 31141413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. From Peptides to Peptidomimetics: A Strategy Based on the Structural Features of Cyclopropane.
    Mizuno A; Matsui K; Shuto S
    Chemistry; 2017 Oct; 23(58):14394-14409. PubMed ID: 28632330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclic Peptides for Protein-Protein Interaction Targets: Applications to Human Disease.
    Rubin S; Qvit N
    Crit Rev Eukaryot Gene Expr; 2016; 26(3):199-221. PubMed ID: 27650985
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Engineering "Antimicrobial Peptides" and Other Peptides to Modulate Protein-Protein Interactions in Cancer.
    Rubin SJS; Qvit N
    Curr Top Med Chem; 2020; 20(32):2970-2983. PubMed ID: 33087030
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Motif mediated protein-protein interactions as drug targets.
    Corbi-Verge C; Kim PM
    Cell Commun Signal; 2016 Mar; 14():8. PubMed ID: 26936767
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modeling and Design of Peptidomimetics to Modulate Protein-Protein Interactions.
    Watkins AM; Bonneau R; Arora PS
    Methods Mol Biol; 2017; 1561():291-307. PubMed ID: 28236245
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Using Peptidomimetics and Constrained Peptides as Valuable Tools for Inhibiting Protein⁻Protein Interactions.
    Robertson NS; Spring DR
    Molecules; 2018 Apr; 23(4):. PubMed ID: 29671834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conversion of Protein Active Regions into Peptidomimetic Therapeutic Leads Using Backbone Cyclization and Cycloscan - How to Do it Yourself!
    Rubin SJS; Tal-Gan Y; Gilon C; Qvit N
    Curr Top Med Chem; 2018; 18(7):556-565. PubMed ID: 29773063
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design and structure of peptide and peptidomimetic antagonists of protein-protein interaction.
    Sillerud LO; Larson RS
    Curr Protein Pept Sci; 2005 Apr; 6(2):151-69. PubMed ID: 15853652
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Computational methods-guided design of modulators targeting protein-protein interactions (PPIs).
    Qiu Y; Li X; He X; Pu J; Zhang J; Lu S
    Eur J Med Chem; 2020 Dec; 207():112764. PubMed ID: 32871340
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biophysical and computational fragment-based approaches to targeting protein-protein interactions: applications in structure-guided drug discovery.
    Winter A; Higueruelo AP; Marsh M; Sigurdardottir A; Pitt WR; Blundell TL
    Q Rev Biophys; 2012 Nov; 45(4):383-426. PubMed ID: 22971516
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting Plasmodium with constrained peptides and peptidomimetics.
    Helton LG; Kennedy EJ
    IUBMB Life; 2020 Jun; 72(6):1103-1114. PubMed ID: 32037730
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting "Undruggable" Proteins: Design of Synthetic Cyclopeptides.
    Russo A; Aiello C; Grieco P; Marasco D
    Curr Med Chem; 2016; 23(8):748-62. PubMed ID: 26758797
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peptides and peptidomimetics as inhibitors of protein-protein interactions involving β-sheet secondary structures.
    Laxio Arenas J; Kaffy J; Ongeri S
    Curr Opin Chem Biol; 2019 Oct; 52():157-167. PubMed ID: 31590141
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibitors of protein-protein interactions (PPIs): an analysis of scaffold choices and buried surface area.
    Ran X; Gestwicki JE
    Curr Opin Chem Biol; 2018 Jun; 44():75-86. PubMed ID: 29908451
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibacterial evaluation of structurally amphipathic, membrane active small cationic peptidomimetics: synthesized by incorporating 3-amino benzoic acid as peptidomimetic element.
    Lohan S; Cameotra SS; Bisht GS
    Eur J Med Chem; 2014 Aug; 83():102-15. PubMed ID: 24953028
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Computer-aided design of amino acid-based therapeutics: a review.
    Farhadi T; Hashemian SM
    Drug Des Devel Ther; 2018; 12():1239-1254. PubMed ID: 29795978
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tailoring peptidomimetics for targeting protein-protein interactions.
    Akram ON; DeGraff DJ; Sheehan JH; Tilley WD; Matusik RJ; Ahn JM; Raj GV
    Mol Cancer Res; 2014 Jul; 12(7):967-78. PubMed ID: 24642350
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Computational peptidology: a new and promising approach to therapeutic peptide design.
    Zhou P; Wang C; Ren Y; Yang C; Tian F
    Curr Med Chem; 2013; 20(15):1985-96. PubMed ID: 23317161
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.